RxDoctor Payments Data

George Artzberger, DO

General Practice · Southfield, MINPI 1578521290

Payments from drug & device makers

$6,711in general payments, 2019–2025

Across 387 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Lilly USA, LLC$732
  • Novo Nordisk$629
  • Amgen$397
  • AbbVie$373
  • Pfizer$322
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,61299%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,711 in reported general payments places this provider in the 95th percentile of 3,051 general practice providers in Michigan.

See all general practice providers in Michigan

Medicare billing

Part B allowed, 2024
$37,443
Medicare patients
83
Services billed
506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$54,324
OzempicSemaglutide42$43,063
JardianceEmpagliflozin19$25,164
XareltoRivaroxaban16$20,528
JanuviaSitagliptin Phosphate12$17,963
OxycontinOxycodone Hcl13$12,991
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,767
Fluticasone-SalmeterolFluticasone Propion/Salmeterol42$7,754
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$6,021
Albuterol Sulfate HfaAlbuterol Sulfate69$2,945
Atorvastatin Calcium203$2,735
Wixela InhubFluticasone Propion/Salmeterol12$2,399
Levothyroxine Sodium126$1,809
Omeprazole79$1,644
PaxlovidNirmatrelvir/Ritonavir11$1,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$322$55,75352 claims
Novo NordiskOzempic$629$43,06342 claims
Boehringer IngelheimJardiance$284$25,16419 claims
Johnson & JohnsonXarelto$215$20,52816 claims
MerckJanuvia$71$17,96312 claims
GSKTrelegy Ellipta$139$7,76712 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$62$1,809126 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$292$51216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,051 general practice providers in Michigan.

Other general practice in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →